Industrial Salt Volume
1.1M tons
-7.2% YoY
Q4 volume impacted by customer deferrals and logistics issues; full year volume up 22% to 4.22M tons.
ARCHEANCHEMICAL
Manufacturing
15 May 2026
Archean Chemical Industries Limited — Q4 FY26
Archean Chemical's Q4 FY26 standalone revenue fell 9% YoY to ₹304.7 crore, with EBITDA down 34.3% to ₹66.4 crore and margin at 21.79%.
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Archean Chemical's Q4 FY26 standalone revenue fell 9% YoY to ₹304.7 crore, with EBITDA down 34.3% to ₹66.4 crore and margin at 21.79%. Industrial salt volumes dropped 7.2% to 1.1 million tons due to customer deferrals from the US-Iran conflict and logistics disruptions from road construction in Kutch, adding ₹14-15 crore in extra costs. Bromine volumes recovered to 3,731 tons (+4% YoY) with realization up 14%, but long-term contract pricing lagged spot. The bromine derivatives business grew 50% YoY but remains at 45% capacity utilization. Management expects logistics normalization by early Q3 FY27 and aims to restore historical margins as external headwinds subside. Key risk: sustained geopolitical tensions could keep commodity and freight costs elevated, delaying margin recovery.
Key Numbers
Bromine Volume
3,731 tons
+4% YoY
Production recovered to historical daily rates of ~55 tons per day by mid-February.
Bromine Realization
+14% YoY
+14% YoY
Pricing actions on select contracts; majority of long-term contracts renegotiated upward.
Bromine Derivatives Revenue
₹23.8 crore
+50% YoY
Full year revenue up ~300% YoY; capacity utilization still at 45%.
Management Guidance
Bromine production growth target of 15% YoY in FY27
Management targets ~15% volume growth in bromine production for FY27, aiming to reach ~25,000 tons annualized.
Management guidance growthLogistics cost normalization by early Q3 FY27
Road construction in Kutch expected to complete by early Q3 FY27, reducing transportation distance and costs.
Management guidance otherHistorical margin recovery as external factors stabilize
Management expects EBITDA margins to return to historical levels once logistics and commodity costs normalize.
Management guidance marginsKey Risks
Sustained geopolitical tensions (US-Iran conflict)
Continued conflict could keep freight and commodity costs elevated, delaying margin recovery.
high · management_commentaryBromine derivatives ramp-up slower than expected
Capacity utilization remains at 45% due to product development delays and pricing pressure; analyst questioned if FY27 targets are achievable.
medium · analyst_questionIndustrial salt pricing pressure from new capacity
New salt capacity in Australia and Middle East adds competitive intensity, pressuring realizations.
medium · management_commentaryOrin Hydrocarbons (mud chemicals) revenue guidance at risk
Gujarat plant awaiting government approvals; product roadmap redefined; analyst noted 150 crore revenue target may be delayed.
medium · analyst_questionNotable Quotes
We have renegotiated a majority of our long-term contracts upwards.
The management has not changed, the management has expanded.
We ended the quarter with roughly around 200 to 220 rupees per ton in increase of cost of transportation.
Frequently Asked Questions
What was Archean Chemical Industries's revenue in Q4 FY26?
Archean Chemical Industries reported revenue of ₹301 Cr in Q4 FY26, representing a -9% change compared to the same quarter last year.
What guidance did Archean Chemical Industries management give for FY27?
Bromine production growth target of 15% YoY in FY27: Management targets ~15% volume growth in bromine production for FY27, aiming to reach ~25,000 tons annualized. Logistics cost normalization by early Q3 FY27: Road construction in Kutch expected to complete by early Q3 FY27, reducing transportation distance and costs. Historical margin recovery as external factors stabilize: Management expects EBITDA margins to return to historical levels once logistics and commodity costs normalize.
What are the key risks for Archean Chemical Industries in FY27?
Key risks include Sustained geopolitical tensions (US-Iran conflict) — Continued conflict could keep freight and commodity costs elevated, delaying margin recovery.; Bromine derivatives ramp-up slower than expected — Capacity utilization remains at 45% due to product development delays and pricing pressure; analyst questioned if FY27 targets are achievable.; Industrial salt pricing pressure from new capacity — New salt capacity in Australia and Middle East adds competitive intensity, pressuring realizations.; Orin Hydrocarbons (mud chemicals) revenue guidance at risk — Gujarat plant awaiting government approvals; product roadmap redefined; analyst noted 150 crore revenue target may be delayed..
Did Archean Chemical Industries meet its previous quarter's guidance?
Scorecard data is being built as historical quarters are processed.
Where can I read the full Archean Chemical Industries Q4 FY26 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.